JUN and hepatocellular carcinoma: Based on previous empirical observation that targeting parallel intracellular signaling or membrane-downstream pathways tend to produce enhanced anticancer effects (Naoum et al., 2018), NF-κB and c-JUN were inferred as key responding elements inducing synergistic anti-HCC effects.